Parkinson's Disease and Its Management: Part 4: Treatment of Motor Complications.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 23 citations in OpenAlex.

1. Dietary Approaches to Improve Efficacy and Control Side Effects of Levodopa Therapy in Parkinson's Disease: A Systematic Review.Advances in nutrition (Bethesda, Md.) · 2021
   Pooled it
2. Cost-utility analysis of a coadjutant telemedicine intervention for fall prevention in Parkinson's disease.European journal of neurology · 2025
   Trial
3. Long-term safety and efficacy of adjunctive rasagiline in levodopa-treated Japanese patients with Parkinson's disease.Journal of neural transmission (Vienna, Austria : 1996) · 2019
   Trial
4. Rethinking the concept of disease modification in an evolving Parkinson's disease treatment landscape.Journal of Parkinson's disease · 2026
   Review
5. Frequency and types of motor fluctuations in patients presenting with advanced Parkinson's disease.Pakistan journal of medical sciences · 2026
   Article
6. Parkinson's disease medication adjustments based on wearable device information compared to other methods: randomized clinical trial.NPJ Parkinson's disease · 2025
   Article
7. Neuropharmacological Interventions of Plant Origin for Parkinson's Disease: A Comprehensive Appraisal.Current neuropharmacology · 2025
   Review
8. Underutilization of Injectable Parkinson's Disease Medication: An Analysis of Neurologist and Patient Perspectives.Movement disorders clinical practice · 2024
   Article
9. Comparison of two types of extension tubes for people with Parkinson's disease in advanced treatment with levodopa-entacapone-carbidopa intestinal gel infusions: a prospective, crossover quality study.BMJ open quality · 2024
   Article
10. Safety and tolerability of long-term apomorphine infusion in advanced Parkinson's disease: an Indian multi-center (APO-IND) experience.Scientific reports · 2023
    Article
11. Safinamide as an Adjunct to Levodopa in Asian and Caucasian Patients With Parkinson's Disease and Motor Fluctuations: A Post Hoc Analysis of the SETTLE Study.Journal of movement disorders · 2023
    Article
12. Elevated Ghrelin Promotes Hippocampal Ghrelin Receptor Defects in Humanized Amyloid-β Knockin Mice During Aging.Journal of Alzheimer's disease : JAD · 2023
    Article
13. The distorted body: The perception of the relative proportions of the body is preserved in Parkinson's disease.Psychonomic bulletin & review · 2022
    Article
14. Professionals' Self-Reported Difficulties towards Integrating Dual Task Training in Care for People with Parkinson's Disease.International journal of environmental research and public health · 2022
    Observational
15. Estimands: bringing clarity and focus to research questions in clinical trials.BMJ open · 2022
    Review
16. Intraperitoneal Administration of Forskolin Reverses Motor Symptoms and Loss of Midbrain Dopamine Neurons in PINK1 Knockout Rats.Journal of Parkinson's disease · 2022
    Article
17. Cost-Effectiveness of Apomorphine Sublingual Film as an "On-Demand" Treatment for "OFF" Episodes in Patients with Parkinson's Disease.Journal of health economics and outcomes research · 2021
    Article
18. Motor Complications of Dopaminergic Medications in Parkinson's Disease.Seminars in neurology · 2017
    Review
19. Nonmotor symptoms in patients with Parkinson disease: A cross-sectional observational study.Medicine · 2016
    Observational
20. Levodopa-accelerated frailty: a hypothesis for a cumulative iatrogenic burden in Parkinson's disease.Frontiers in neurology
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract